ABR
Gene Information
- Official Symbol: ABR
- Official Name: ABR activator of RhoGEF and GTPase
- Aliases and Previous Symbols: N/A
- Entrez ID: 29
- UniProt: Q12979
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: This gene encodes a protein that is similar to the protein encoded by the breakpoint cluster region gene located on chromosome 22. The protein encoded by this gene contains a GTPase-activating protein domain, a domain found in members of the Rho family of GTP-binding proteins. Functional studies in mice determined that this protein plays a role in vestibular morphogenesis. Alternatively spliced transcript variants have been reported for this gene. [provided by RefSeq, Feb 2012].
- UniProt Summary: N/A
Pfam Domains GO Terms
Pfam Domains
| RhoGAP |
| PH |
| C2 |
| RhoGEF |
GO Terms
| negative regulation of neutrophil degranulation |
| negative regulation of blood vessel remodeling |
| negative regulation of neutrophil activation |
| regulation of neutrophil degranulation |
| regulation of blood vessel remodeling |
| negative regulation of cellular extravasation |
| regulation of neutrophil activation |
| negative regulation of myeloid leukocyte mediated immunity |
| negative regulation of leukocyte degranulation |
| postsynaptic density, intracellular component |
| negative regulation of tissue remodeling |
| negative regulation of regulated secretory pathway |
| regulation of cellular extravasation |
| negative regulation of exocytosis |
| regulation of vascular permeability |
| negative regulation of leukocyte migration |
| negative regulation of leukocyte mediated immunity |
| regulation of leukocyte degranulation |
| neuromuscular process controlling balance |
| regulation of myeloid leukocyte mediated immunity |
| positive regulation of phagocytosis |
| Rho guanyl-nucleotide exchange factor activity |
| regulation of tissue remodeling |
| Schaffer collateral - CA1 synapse |
| regulation of phagocytosis |
| activation of GTPase activity |
| inner ear morphogenesis |
| guanyl-nucleotide exchange factor activity |
| neuromuscular process |
| ear morphogenesis |
| negative regulation of immune effector process |
| negative regulation of inflammatory response |
| regulation of Rho protein signal transduction |
| negative regulation of immune response |
| regulation of regulated secretory pathway |
| vascular process in circulatory system |
| negative regulation of leukocyte activation |
| inner ear development |
| regulation of leukocyte migration |
| negative regulation of cell activation |
| negative regulation of secretion by cell |
| regulation of leukocyte mediated immunity |
| negative regulation of defense response |
| ear development |
| regulation of exocytosis |
| negative regulation of secretion |
| regulation of Ras protein signal transduction |
| sensory organ morphogenesis |
| negative regulation of cell migration |
| negative regulation of cell motility |
| GTPase activator activity |
| embryonic organ morphogenesis |
| negative regulation of cellular component movement |
| response to lipopolysaccharide |
| small GTPase mediated signal transduction |
| negative regulation of locomotion |
| response to molecule of bacterial origin |
| regulation of inflammatory response |
| regulation of small GTPase mediated signal transduction |
| glutamatergic synapse |
| negative regulation of response to external stimulus |
| blood circulation |
| circulatory system process |
| positive regulation of GTPase activity |
| embryonic organ development |
| negative regulation of immune system process |
| modulation of chemical synaptic transmission |
| regulation of trans-synaptic signaling |
| regulation of immune effector process |
| regulation of GTPase activity |
| negative regulation of transport |
| actin cytoskeleton organization |
| sensory organ development |
| regulation of vesicle-mediated transport |
| embryonic morphogenesis |
| actin filament-based process |
| regulation of leukocyte activation |
| regulation of cell activation |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| response to bacterium |
| positive regulation of cell death |
| brain development |
| regulation of secretion by cell |
| regulation of defense response |
| positive regulation of hydrolase activity |
| head development |
| regulation of secretion |
| regulation of cell migration |
| response to lipid |
| regulation of cell motility |
| negative regulation of developmental process |
| animal organ morphogenesis |
| embryo development |
| central nervous system development |
| regulation of locomotion |
| positive regulation of transport |
| regulation of cellular component movement |
| regulation of anatomical structure morphogenesis |
| regulation of response to external stimulus |
| cytoskeleton organization |
| regulation of immune response |
| negative regulation of multicellular organismal process |
| regulation of hydrolase activity |
| response to other organism |
| response to external biotic stimulus |
| G protein-coupled receptor signaling pathway |
| response to biotic stimulus |
| nervous system process |
| positive regulation of catalytic activity |
| regulation of response to stress |
| regulation of apoptotic process |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| negative regulation of response to stimulus |
| regulation of immune system process |
| regulation of cell death |
| intracellular signal transduction |
| positive regulation of molecular function |
| regulation of intracellular signal transduction |
| regulation of transport |
| system process |
| membrane |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| WNT3A 44ng/ml R08 exp537 | -2.02 |
| UNC2400 2μM R03 exp156 | -1.72 |
| 42°C R08 exp539 | 1.88 |
| Sulforaphane 9μM R08 exp525 | 1.93 |
Most Correlated Genes in Chemogenomics
No correlation found to any other genes in chemogenomics.
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 13254
- Expression level (log2 read counts): 2.18
Expression Distribution
ABR Expression in NALM6 Cells: 2.18